AIM2 and malignant colon neoplasm: Therefore, taking into account epigenetic factors reflecting the individual metabolic differences of patients with colon cancer, further studies on the direct/indirect involvement of eicosanoids (including PGE2) in the regulation of AIM2 activity would be helpful in the development of targeted therapies against colon cancer.